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Abstract
Background: Decades of genome-wide association studies (GWAS) have accumulated large volumes of genomic
data that can potentially be reused to increase statistical power of new studies, but different genotyping platforms
with different marker sets have been used as biotechnology has evolved, preventing pooling and comparability of
old and new data. For example, to pool together data collected by 550K chips with newer data collected by 900K
chips, we will need to impute missing loci. Many imputation algorithms have been developed, but the posteriori
probabilities estimated by those algorithms are not a reliable measure the quality of the imputation. Recently,
many studies have used an imputation quality score (IQS) to measure the quality of imputation. The IQS requires
to know true alleles to estimate. Only when the population and the imputation loci are identical can we reuse the
estimated IQS when the true alleles are unknown.
Methods: Here, we present a regression model to estimate IQS that learns from imputation of loci with known
alleles. We designed a small set of features, such as minor allele frequencies, distance to the nearest known cross-
over hotspot, etc., for the prediction of IQS. We evaluated our regression models by estimating IQS of imputations
by BEAGLE for a set of GWAS data from the NCBI GEO database collected from samples from different ethnic
populations.
Results: We construct a ν-SVR based approach as our regression model. Our evaluation shows that this regression
model can accomplish mean square errors of less than 0.02 and a correlation coefficient close to 0.75 in different
imputation scenarios. We also show how the regression results can help remove false positives in association
studies.
Conclusion: Reliable estimation of IQS will facilitate integration and reuse of existing genomic data for meta-
analysis and secondary analysis. Experiments show that it is possible to use a small number of features to regress
the IQS by learning from different training examples of imputation and IQS pairs.
Background
In the past decade, the data sets collected for genome wide
association studies (GWAS) have grown geometrically.
Reusing these valuable data in new studies is difficult
because they are collected through different study designs
and on different platforms. Various imputation algorithms
(e.g., IMPUTE [1], BEAGLE [2-7], and MACH [8]) have
been developed to predict the individual genotypes at
un-typed markers. Although these imputation algorithms
have already been put to use, the methods of measuring
imputation quality are still rarely addressed. The imputa-
tion quality score of the single-nucleotide polymorphism
(SNP) genotypes are quite different at distinct loci. For
this reason, we want to investigate how to measure the
imputation quality for a particular SNP that is imputed by
these algorithms. After the imputation quality measure-
ment is established, researchers can pay more attention to
those poorly-imputed SNPs in the data integration pro-
cess. Recently, [9] proposed a new statistic for assessing
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the imputation reliability and it is designated as the impu-
tation quality score (IQS). The IQS has been shown to be
commensurate with the true quality of the imputation and
successfully applied to filter false positive associations in
GWAS studies that use imputed genotypes [9].
The IQS for each imputed SNP is computed by two
scores, the proportion of observed agreement (Po) and
the proportion of chance agreement (Pc), to account not
just for the accuracy of the imputation but also whether
it is accurate by chance alone. In detail, the computation
of IQS requires the posterior probabilities of AA, AB
and BB as output by the imputation program. For one
SNP genotyped on N individuals, the probabilities can
be readily constructed as shown in Table 1 where each
cell, nij, represents the number of individuals with true
genotype j and imputed genotype i. The observed agree-





Po, The chance agreement Pc is defined as the propor-





, where ni., n.i, and n.. are defined in Table 1.
Then IQS is calculated by the Cohen’s kappa coefficient
[10] and is defined as a function of Po and Pc as
IQS = Po−Pc1−Pc .
Assessment of Po, Pc, and IQS needs the true genotypes
to be known. [9] showed that for the same population
and the same locus imputed using the same set of loci
with known genotypes, the estimated IQS are highly cor-
related. We showed it by dividing a sample by half and
imputing SNPs of the Illumina 1 M array using the SNP
genotyping results from the Illumina 550 K array, and
then we estimated the IQS scores. We obtained a correla-
tion coefficient of 0.99 for the IQS scores for the same set
of imputed SNPs. That is, we can expect that IQS scores
will be nearly the same if the population, the imputed
SNPs, and the SNPs of known genotypes, are identical. If
there are previously estimated IQS scores available that
match these conditions, then the scores can be reused.
Therefore, it is possible to obtain IQS scores without
knowing true genotypes by querying the IQS from a pre-
constructed IQS database.
However, exhausting all populations and combinations
of imputation loci to establish such a database of all
useful IQS may take considerable resources. Here, we
try to develop a computational method to estimate IQS
without known true genotypes. We assess whether or
not it is possible to build a regression model from impu-
tations of SNP sites with known alleles, and then use the
regression model to estimate IQS for SNPs with
unknown alleles. The idea is to use additional statistical
information to build a regression model to predict the
IQS. Also, in practice, people work with specific sets of
variants and this method will facilitate creation of a
database of the IQS of those variants.
Methods and materials
ν-Support vector regression
In a multi-dimensional regression problem, we have a
data set of l d-dimensional independent variables xi Î ℝ
d,
i = 1,..., l and dependent variables yi Î ℝ. In our IQS
regression problem, yi represents the true IQS and xi
denotes the input feature vector. The goal is to find a
function that approximates yi. A solution of this problem
based on a kernel method is to find the function yi ≈ f(xi,
w, b) = w.  (xi) - b, where w and b Î ℝ
d are parameters
and  : ℝd ® ℝd is a mapping such that there exists a
kernel function that computes the inner product  (xi). 
(xj) = k(xi, xj). Because the radial basis function (RBF) can
preserve a relatively high accuracy in comparison with
other kernel functions (data not shown), our choice of
the kernel function is the RBF kernel [11,12].
Many models and algorithms have been developed to
search for the parameters w and b of the regression
function that maximally ts the input set of data. The
ε-Support Vector Regression model (ε-SVR) is one of











yi − w · ϕ(xi) − b ≤ ε + ξi
w · ϕ(xi) + b − yi ≤ ε + ξ∗i
ξi, ξ∗i ≥ 0.
(1)
The parameter C is used to determine the complexity
of model and controls the tradeoff between the training
error minimization and the model complexity. If it is
too small, the model may underfit the data. The para-
meter ε serves as the tolerance of errors of the regres-
sion. Combined with the slack variables ξi ξ
∗
i we have a
soft-margin approach to regression that can be flexibly
adjusted [11,12].
The ν-Support Vector Regression (ν-SVR) introduces
another parameter ν in the formulation, which is proven
to be easier to adjust than C. One of the reasons is that
Table 1 Marginal cross classification of the genotypes
used for the computation of IQS
True genotypes
Imputed Genotypes AA AB BB Total
AA n11 n12 n13 n1.
AB n21 n22 n23 n2.
BB n31 n32 n33 n3.
Total n.1 n.2 n.3 n..
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yi − w · ϕ(xi) − b ≤ ε + ξi
w · ϕ(xi) + b − yi ≤ ε + ξ∗i
ξi, ξ∗i ≥ 0, ε ≥ 0
(2)
Moreover, the parameter ν can serve as an upper bound
for the fraction of margin errors, and a lower bound for
the fraction of the number of support vectors. In compari-
son with C, to select a suitable ν would be more intuitive
[13,14]. Therefore, we chose ν-SVR over ε-SVR for our
IQS prediction model. This model is also known to pro-
vide high out-of-sample generalization performance.
We chose LibSVM [16] as our implementation of the ν-
SVR model. The parameter g in the radial basis function
is set as 1/d. The parameter ν was searched within {0.1,
0.2, 0.3, . . . 1.0} and an optimal value of ν were selected
by applying a 10-fold cross validation on the training
data set. The regression model can be applied to approxi-
mate Po and Pc as well as the IQS.
Features generation
Other regression models can also be used but the key to
the success is to identify a set of variables that influence
the imputation quality as the input features xi in the
regression model. We intended to use all useful infor-
mation related to imputation quality as features for the
regression model. Under consideration of the statistical
correlation analysis (data not shown), we selected the
following 12 defined features of a SNP whose allele we
want to impute within a given sample.
1. Chromosome position: The chromosome where
the SNP located.
2. Physical position: The position of the imputed
SNP in bp.
3. Minor allele frequency (MAF): Previously, [9] have
shown that the minor allele frequency is an impor-
tant variable correlated with the true IQS. The
above three features are available in the annotation
file from the genotyping platform provider.
4. B allele frequency: This is derived from the allele
signal intensity measurement for each locus of each
individual in the raw CEL files. The raw CEL files
are available from the Hapmap samples [17]. For
each imputed SNP, we used the mean of the B allele
frequency of the SNP on the samples of the corre-
sponding ethnic population.
5. MAF in the reference panel: In addition to using
the available MAF provided by the annotation file,
we also consider the MAF in the reference panel.
6. Ratio of genotypes AA/AB: It is used to to indi-
cate the proportion of genotype AA for each
imputed SNP in the reference panel.
7. Ratio of genotypes BB/AB: Similar to feature 6, it
is used to to indicate the proportion of genotype BB
for each imputed SNP in the reference panel.
8. Distance to the nearest genotyped SNP: This is to
capture an indication that the imputation quality
will be better if the nearest genotyped SNP in the
inference panel is closer.
9. Distance to the nearest recombination hotspot: The
distance to the nearest recombination hotspot also
plays an important role in the quality of the imputa-
tion. We used the recombination rates and hotspots
available in the release version phase II build b35 to
GRCh37 from the International HapMap Project [17].
10. The nearest recombination hotspot’s recombina-
tion rate (cM/Mb, centiMorgans per megabase): This
variable is important in the imputation process. The
IMPUTE2 program uses it explicitly as a required
input for the imputation [1,18].
11. Posterior probability estimated by the imputation
program: This variable is available from the output of
the imputation program. The Beagle program pro-
vides the genotype probabilities file and the genotype
dosage file. We used the mean values of the posterior
probabilities estimated for all the individuals in the
inference panel.
12. B-allele dosage: Given the posterior genotype
probabilities for a SNP (Pr(AA), Pr(AB), and Pr(BB)),
the estimated B-allele dosage for each individual is
equal to 0 × Pr(AA) + 1 × Pr(AB) + 2 × Pr(BB),
which is reported in the genotype dosage file. We
used the mean values of the B-allele dosage values of
all the individuals in the inference panel.
It is worth mentioning that the posterior probability
estimated by the imputation program and the B-allele
dosage are highly correlated to predicting the IQS under
the statistical correlation analysis. These features will be
used in the regression model for the IQS as well as the
regression for the observed agreement Po and the
chance agreement Pc. We will show that these 12 fea-
tures are useful to construct an adequate regression
model.
Data preparation
We prepared three data sets to evaluate the perfor-
mance of our regression models. These data sets contain
genotyping results of samples chosen to cover different
ethnic backgrounds collected in different disease studies.
We selected recent data sets genotyped with advanced
platforms that cover a large number of SNPs so that we
can flexibly keep those SNPs covered by old, obsolete
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platforms (with less SNPs probed) and hold out the rest
to impute. Meanwhile, since we have their true geno-
types, we can use the true genotypes of these SNPs as
the gold standard to evaluate imputation quality and
regression.
The Merlion Lung Cancer Study 2 DNA [19] and Oral
Squamous Cell Carcinoma samples [20] from the NCBI
GEO database [21] were used for evaluating the regres-
sion model. The Merlion Lung Cancer samples consist of
two ethnic populations, East-Asian (EA) and Western-
European (WE). Samples were all genotyped on the Affy-
metrix Genome-Wide Human SNP Array 6.0 platform.
This platform contains more than 906,600 SNP probes,
including the historical 482,000 SNPs in the Affymetrix
GeneChip Human Mapping 500K Array Set. After the
preprocessing of raw CEL files, there are 763,252 SNPs
reported for the EA population of Merlion Lung Cancer
samples, 778,058 SNPs for the WE population of Merlion
Lung Cancer samples, and 693,494 SNPs for the oral
Squamous Cell Carcinoma samples.
Regression performance evaluation
We designed scenarios to simulate the imputation of
missing SNPs in a data set genotyped using an old plat-
form to the large set of SNPs on the Affymetrix SNP 6.0
array. These scenarios involve a training set to construct
our regression model in advance. This involves holding
out a set of SNPs to impute, evaluating true IQS with
known alleles, using the true IQS to train the regression
model. Then the trained regression model can be applied
to estimate IQS of imputed SNPs in a test set, where a set
of SNPs is assumed to have missing genotypes. The
design of the scenarios is to create different combinations
of the training and test sets and see how the regression
performance is affected.
To create both training and test sets, we basically
divided the SNPs on the Affymetrix SNP 6.0 array into
two sets. One contains those SNPs genotyped in both an
old platform and Affymetrix SNP 6.0 array. This set
simulates SNPs with “known” genotypes to be used to
impute other SNPs. The other contains the remaining
SNPs covered only by the Affymetrix SNP 6.0 array. This
set simulates “missing” SNPs to be imputed.
Table 2 and Table 3 show our design of training and
test sets for four scenarios to evaluate generalization of
the regression model. Scenario 1 is the simplest case,
which tests the regression performance when a sample of
the same ethnic and disease phenotype is used for train-
ing. We used the WE lung cancer sample to create the
training set. Alleles of the randomly picked 10% of SNPs
of the training set were erased, denoted as “missing.”
Under the Affymetrix 500k array, these “missing” SNPs
were imputed using the other 90% genotyped SNPs to a
full set of SNPs on the same platform. As a result, there
are 41,304 SNPs of the WE lung cancer sample used for
the model training. We also used the WE lung cancer
sample to create the test set, which consists of 320,172
SNPs covered only by the Affymetrix SNP 6.0 array.
Their genotypes were then imputed from SNPs covered
by the Affymetrix mapping 500k array and our regression
model was applied to assess the imputation quality.
In Scenario 2, the generalization performance of our
IQS regression model was evaluated when it was trained
using “known” and “missing” SNPs covered by platforms
different from those to be used in testing. We used the
WE lung cancer sample again but used the Illumina
550k array instead of the Affymetrix SNP 6.0 array to
choose SNPs. There are 41,304 SNPs of the WE lung
cancer sample on the Illumina 550k array. After the
regression model is constructed, we then used the same
test set created in Scenario 1.
In Scenario 3, our IQS regression model is applied to
different ethnic populations. We used the EA lung can-
cer sample to create the training set, resulting in 37,611
Table 2 Summary of training set composition for different evaluation scenarios
Scenarios Ethnic population Samples from Platform to Platform
Scenario 1 Western European Lung cancer from Affymetrix 500k to Affymetrix 500k
Scenario 2 Western European Lung cancer from Illumina 550k to Illumina 550k
Scenario 3 East Asian Lung cancer from Affymetrix 500k to Affymetrix 500k
Scenario 4 East Asian Lung cancer from Affymetrix 500k to Affymetrix 500k
Table 3 Summary of test set composition for different evaluation scenarios
Scenarios Ethnic population Samples from Platform to Platform
Scenario 1 Western European Lung cancer from Affymetrix 500k to Affymetrix SNP 6.0
Scenario 2 Western European Lung cancer from Affymetrix 500k to Affymetrix SNP 6.0
Scenario 3 Western European Lung cancer from Affymetrix 500k to Affymetrix SNP 6.0
Scenario 4 East Asian Oral cancer from Affymetrix 500k to Affymetrix SNP 6.0
High-lighted fields are the settings that are different from the training set used in the corresponding scenarios.
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SNPs of the EA lung cancer sample on the Affymetrix
500k array. The regression model constructed by the EA
lung cancer samples was used to predict the IQS of
SNPs of the WE lung cancer samples as in Scenario 1.
Scenario 4 tests if our regression model can be gener-
alized across samples collected for different disease stu-
dies. We used the same training set as in the scenarios
above and used the EA Oral Squamous Cell Carcinoma
sample as the test set. This test set also simulates impu-
tation from the Affymetrix mapping 500k array to the
Affymetrix SNP 6.0 array and consists of 320,172 SNPs.
For all scenarios, we chose the imputation program Bea-
gle. Beagle is based on the Hidden Markov Model (HMM)
[22]. To estimate missing alleles, an EM algorithm is
adopted to optimize the parameters to fit the HMM model
from a given genotyped reference panel [2,7]. In terms of
imputation accuracy, Beagle perform as well as other impu-
tation programs but is known to be more efficient with
regard to running time and memory space required [23].
The 1000 Genomes Project samples (August 2010
release) served as the reference panel. As the larger
reference panel has developed, researchers have become
more confident to combine two studies or extend a spe-
cific study on different platforms [23]. We removed
Table 4 Summary of the IQS regression results for each
scenario
IQS regression results
Scenario Mean Squared Error Correlation Coefficient
Scenario 1 0.0182 0.740
Scenario 2 0.0174 0.748
Scenario 3 0.0178 0.736
Scenario 4 0.0197 0.751
Figure 1 IQS regression results, (A) Scenario 1, evaluating the regression result on the same platform. (B) Scenario 2, evaluating the regression
result on different platforms. (C) Scenario 3, evaluating the regression result on the different ethnic population. (D) Scenario 4, under the same
ethnic population, evaluating the regression result on the different disease samples.
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Table 5 Summary of the Po regression results for each scenario
Po regression results
Scenario Mean Squared Error Correlation Coefficient
Scenario 1 0.00248 0.840
Scenario 2 0.00249 0.838
Scenario 3 0.00256 0.835
Scenario 4 0.00301 0.831
Table 6 Summary of the Pc regression results for each scenario
Pc regression results
Scenario Mean Squared Error Correlation Coefficient
Scenario 1 0.00062 0.990
Scenario 2 0.00072 0.988
Scenario 3 0.00071 0.989
Scenario 4 0.00099 0.984
Figure 2 Poregression results, (A) Scenario 1, evaluating the regression result on the same platform. (B) Scenario 2, evaluating the regression
result on different platform. (C) Scenario 3, evaluating the regression result on the different ethnic population. (D) Scenario 4, under the same
ethnic population, evaluating the regression result on the different disease samples.
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those SNPs with MAF less than 1% that usually lead to
decreased imputation accuracy [9,23]. About 2% of
SNPs were removed before the imputation. Notably,
there are a few SNPs with inconsistent genotyped mar-
kers compared to the reference panel. These few SNPs
(< 0.01%) will be excluded from the training or test set
in order to focus only on the reasonable imputation
results.
Results and discussion
Table 4 shows the regression performance of our model
for predicting the IQS under different model training and
imputation scenarios and Figure 1 shows the scatter plot.
The results show that our regression model achieved
mean square errors less than 0.02 and correlation coeffi-
cients close to 0.75. The performance is consistent across
different scenarios, suggesting that the regression model
generalizes equally well in different scenarios. However,
Figure 1 shows that regression value usually overestimated
values, especially for low IQS imputations.
The best performance was accomplished in Scenario
2, where the regression model was trained with a set of
SNPs derived from different platforms from the test,
suggesting that training with a wider variety of SNPs
might allow the model to generalize better. The worst
performance was from Scenario 4, where samples from
studies of different diseases were tested. Nevertheless,
the performance difference was not significant.
Tables 5, 6 and Figures 2, 3 show the regression
results for Po and Pc, respectively. It turned out that the
results are better than those for the regression of the
IQS. The result for Pc is particularly good because Pc is
just the marginals. One may speculate that it may be
useful to predict Po and Pc separately and then combine
Figure 3 Pcregression results, (A) Scenario 1, evaluating the regression result on the same platform. (B) Scenario 2, evaluating the regression
result on different platform. (C) Scenario 3, evaluating the regression result on the different ethnic population. (D) Scenario 4, under the same
ethnic population, evaluating the regression result on the different disease samples.
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them to obtain the estimated IQS. We tried this
approach but the results were similar to directly predict-
ing the IQS.
We also performed a test to evaluate whether we can
use the regression results to filter out false positives in a
GWAS. Previously, [9] showed that by setting a suitable
threshold for the true IQS a better filtering rate can be
accomplished than by using the imputation accuracy,
which is equivalent to Po. In this test, we assumed that
an imputation with a true IQS below a certain threshold
can be considered as a true flase positive that must be
filtered out. Under this assumption, we plotted the
Receiver Operating Characteristic (ROC) curve of the
regression results against the presumed false positives.
The results are presented as Figure 4 and 5. The pre-
dicted IQS can accomplish the Area Under Curve
(AUC) value more than 0.96 when the threshold is set
to 0.5, and more than 0.80 when threshold is 0.9. As [9]
suggested previously, the imputation accuracy may over-
estimate the quality of imputation. The results shown in
Figure 4 and 5 show that the predicted IQS performs
better than the predicted imputation accuracy with a
larger AUC in all four scenarios, suggesting that the
predicted IQS can filter out more presumed false posi-
tives than the predicted imputation accuracy, and the
results are consistent in all four scenarios. We also
show the curves of the true imputation accuracy as a
reference.
Conclusion
We propose a ν-SVR based approach to the estimation
of the true IQS of imputations of SNPs with unknown
Figure 4 ROC curve at the threshold = 0.5, (A) Scenario 1, AUC(Predicted IQS):0.9617, AUC(True Imputation Accuracy):0.9718, and AUC(Predicted
Imputation Accuracy):0.9354 (B) Scenario 2, AUC(Predicted IQS):0.9739, AUC(True Imputation Accuracy):0.9783, and AUC(Predicted Imputation
Accuracy):0.9539 (C) Scenario 3, evaluating the regression result on the different ethnic population, AUC(Predicted IQS):0.9642, AUC(True
Imputation Accuracy):0.9677, and AUC(Predicted Imputation Accuracy):0.9072 (D) Scenario 4, AUC(Predicted IQS):0.9656, AUC(True Imputation
Accuracy):0.9758, and AUC(Predicted Imputation Accuracy):0.9223
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true genotypes. We show that our regression model
generalizes equally well across SNP selections by differ-
ent platforms and across different ethnic groups and
disease populations. The model performed particularly
well for predicting the true chance agreement of impu-
tation. We also showed that the estimated IQS can be
used to filter false positive associations in a GWAS to
some extent. The results suggest that it is feasible to
apply a regression model to predict the true IQS.
Our future work includes an effort to extend the fea-
ture set to improve the regression performance for pre-
dicting Po and the IQS and to pool together a wide
variety of data sets including different SNPs and popula-
tions as the training examples so that one model can be
used to estimate the IQS for all imputations. When the
model is sufficiently robust, our long-term goal is to
impute to the same size all genotype data in repositories
of GWAS data (to as large as the most advanced plat-
forms) and apply this regression model to attach an esti-
mated IQS to all imputations in addition to the
posteriori probability from the imputation program and
make the results available in the public domain.
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